Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
An empirical approach to determine a threshold for assessing overdispersion in Poisson and negative binomial models for count data.
2018 Jul 05
Payne, E.H., Gebregziabher, M., Hardin, J.W., Ramakrishnan, V., Egede, L.E.
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood.
2019 Jan
Sahly, H.M.El, Gorchakov, R., Lai, L., Natrajan, M.S., Patel, S.M., Atmar, R.L., Keitel, W.A., Hoft, D.F., Barrett, J., Bailey, J., Edupuganti, S., Raabe, V., Wu, H.M., Fairley, J., Rouphael, N., Murray, K.O., Mulligan, M.J.
Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.
2019 01
Kotloff, K.L., Shirley, D.A.T., Creech, B., Frey, S.E., Harrison, C.J., Staat, M., Anderson, E.J., Dulkerian, S., Thomsen, I.P., Al-Hosni, M., Pahud, B.A., Bernstein, D.I., Yi, J., Petrikin, J.E., Haberman, B., Stephens, K., Stephens, I., Oler, R.E., Conrad, T.M.
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.
2019 09
Rouphael, N.G., Hurwitz, S.J., Hart, M., Beck, A., Anderson, E.J., Deye, G., Osborn, B., Cai, S.Yi, Focht, C., Amegashie, C., Bowlin, T.L., Brooks, J., Mulligan, M.J.
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.
2019 09
Modjarrad, K., Roberts, C.C., Mills, K.T., Castellano, A.R., Paolino, K., Muthumani, K., Reuschel, E.L., Robb, M.L., Racine, T., Oh, M.D., Lamarre, C., Zaidi, F.I., Boyer, J., Kudchodkar, S.B., Jeong, M., Darden, J.M., Park, Y.K., Scott, P.T., Remigio, C., Parikh, A.P., Wise, M.C., Patel, A., Duperret, E.K., Kim, K.Y., Choi, H., White, S., Bagarazzi, M., May, J.M., Kane, D., Lee, H., Kobinger, G., Michael, N.L., Weiner, D.B., Thomas, S.J., Maslow, J.N.
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
2019
Carter, C., Houser, K.V., Yamshchikov, G.V., Bellamy, A.R., May, J., Enama, M.E., Sarwar, U., Larkin, B., Bailer, R.T., Koup, R., Chen, G.L., Patel, S.M., Winokur, P., Belshe, R., Dekker, C.L., Graham, B.S., Ledgerwood, J.E.
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with
2019 Mar
Bolaños-Meade, J., Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadhimi, Z., Alousi, A.M., Antin, J.H., Arai, S., Bickett, K., Bin Chen, Y., Damon, L.E., Efebera, Y.A., Geller, N.L., Giralt, S.A., Hari, P., Holtan, S.G., Horowitz, M.M., Jacobsohn, D.A., Jones, R.J., Liesveld, J.L., Logan, B.R., MacMillan, M.L., Mielcarek, M., Noel, P., Pidala, J., Porter, D.L., Pusic, I., Sobecks, R., Solomon, S.R., Weisdorf, D.J., Wu, J., Pasquini, M.C., Koreth, J.
Clinical trials referral resource. Clinical trials of dolastatin-10.
1999 Jan
Wright, J.J., Blatner, G., Cheson, B.D.
Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777.
1999 Nov
Wright, J., Blatner, G.L., Cheson, B.D.